Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545

Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications

Brownlee, M., Vlassara, H., & Cerami, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,010

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848

Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780

Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins

Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 773

The Pathogenesis of Senile Plaques

DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753

New Aspects of the Maillard Reaction in Foods and in the Human Body

Ledl, F., & Schleicher, E. D. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199005653 · Cited by 738

Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715

Immune signaling and function in neurodegeneration

Latour, Y. L., & McGavern, D. B. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199850 · Cited by 9

Alzheimer’s Disease is Driven by Beta-Amyloid Generated in the Amyloid Precursor Protein-Independent Pathway and Retained Intraneuronally: Research and Therapeutic Strategies in a New AD Paradigm

Volloch, V., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.-v2-id1010 · Cited by 6

Diabetes and cognitive dysfunction

Kim, B., Sims‐Robinson, C., Sakowski, S. A., & Feldman, E. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00027-7 · Cited by 8

ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer’s Disease: Origins, Progression, and Therapeutic Strategies

Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116036 · Cited by 6

Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease

Deng, S., Peng, Y., Xu, M., Yi, Q., & Feng, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002214 · Cited by 5

Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review

Ahmad, S. S., Younis, K., Jeandet, P., Aschner, M., & Khan, H. Z. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210811160007 · Cited by 5

Bovine Spongiform Encephalopathy: Are the Cows Mad or Full of Carbohydrates?

Frey, J. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.018 · Cited by 5

Effects of Amyloid Beta Peptide on Neurovascular Cells

Askarova, S., Tsoy, A., Shalakhmetova, T. M., & Lee, J. C. (2013) · Central Asian Journal of Global Health · doi:10.5195/cajgh.2012.4 · Cited by 5

A study on appetite of overweight/obese patients with type 2 diabetes mellitus based on multimodal magnetic resonance imaging

Gao, M., Gong, L., Zeng, Y., Li, D., Wen, J., Guo, Y., Li, Z., Luo, J., Chen, C., & Wen, G. (2025) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2025.1615654 · Cited by 4

Contribution of Diabetes and Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease

Farooqui, A. A., & Farooqui, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00019-5 · Cited by 4

Are advanced glycation end‐products specific biomarkers for Alzheimer's disease?

Staniszewska, M. M., Leszek, J., Małyszczak, K., & Gamian, A. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1372 · Cited by 4

Cognitive Decline and Diabetes

Barbieri, M., Boccardi, V., & Paolisso, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00035-5 · Cited by 4

Frailty and aging are associated with cognitive decline and dermal advanced glycation end-product accumulation in older Japanese men

Takei, S., Ochi, M., Shiraoka, A., Matsumoto, S., Fujishita, S., Okada, Y., Miura, S., Ochi, H., Igase, M., & Ohyagi, Y. (2024) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2024.100071 · Cited by 3

An introduction to innate immunity in the central nervous system

Harry, G. J., Childers, G. M., & McPherson, C. A. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.002 · Cited by 3

Glucose- and Fructose-Induced Toxicity in the Liver and Brain

Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_2 · Cited by 3

Effect of Dietary Phytochemicals on Metabolic Syndrome and Neurological Disorders

Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_6 · Cited by 3

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease

Bonds, J. A., Hart, P. C., Minshall, R. D., Lazarov, O., Haus, J. M., & Bonini, M. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00013-9 · Cited by 3

BSE: a consequence of cattle feeding with glycated molecules host-unknown?

Boratyński, J., & Górski, A. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1519 · Cited by 3

Understanding the neurobiological mechanisms of learning and memory: cellular, molecular and gene regulation implicated in synaptic plasticity and long-term potentiation. Part IV A

Leff, P., Retana, I., Caballero, A. A., Zavala, E., Loría, F., Pavón, L., & Antón, B. (2004) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 3

Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer’s Disease

Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189913 · Cited by 3

Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer’s Disease-Affected Neurons: Contesting the ‘Obvious’

Volloch, V., & Rits‐Volloch, S. (2025) · Genes · doi:10.3390/genes16010046 · Cited by 3

Neurochemical Effects of Long Term Consumption of Simple Carbohydrates

Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_3 · Cited by 2

Origin(s) of Intraneuronal Amyloid

D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00002-4 · Cited by 2

Compilation and Analysis of Enzymes, Engineered Antibodies, and Nanoparticles Designed to Interfere with Amyloid‐β Aggregation

Zhao, J., Ma, B., & Nussinov, R. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600093 · Cited by 2

A Molecular Dynamics Study on RAGE-Aβ42 Interaction and the Influence of G82S RAGE Polymorphism on Aβ Interaction

Krishnan, S., Ravi, S., Ponmalai, S., & Rani, P. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2

Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2

Role of Advanced Glycated End Products (AGEs) in Predicting Diabetic Complications Using Machine Learning Tools: A Review from Biological Perspective

Battula, V. K., Satheesh, P., Srinivas, B., Sekhar, A. C., & Sujatha, V. A. (2020) · Lecture notes in electrical engineering · doi:10.1007/978-981-15-7961-5_138 · Cited by 2

Endogenous free radicals and antioxidants in the brain

Marklund, S. L. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.002 · Cited by 2

Alzheimer’s Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory

Volloch, V., & Rits‐Volloch, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094252 · Cited by 3

Contribution of Receptors, Transcription Factors, and Genes in the Induction of Neuroinflammation

Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_4 · Cited by 1

Diabetes as a Model of Premature Aging

Mooradian, A. D. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50057-6 · Cited by 1

Contribution of Dietary Carbohydrates in Induction of Oxidative Stress

Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_8 · Cited by 2

REDUCED RAGE mRNA IN MONONUCLEAR BLOOD CELLS OF PATIENTS WITH PROBABLE ALZHEIMER DISEASE

Poulopoulou, C., Davaki, P., Sgouropoulos, P., Tsaltas, E., Nikolaou, C., Orfanioutou, F., & Vassilopoulos, D. (2008) · Neurology · doi:10.1212/01.wnl.0000297196.34007.8a · Cited by 1

Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity

Kayed, R., & Lasagna‐Reeves, C. A. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0001 · Cited by 2

Possible Detrimental Role of Astrocytic Activation during the Subacute Phase of Permanent Focal Cerebral Ischemia in the Rat

Mori, T., Tateishi, N., & Asano, T. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch17 · Cited by 1

Insulin resistance and stroke

Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00005-5 · Cited by 1

Idendification de gènes à effet de dose impliqués dans la pathophysiologie des aneuploïdies associées au chromosome 21

Dalloneau, E. (2010) · theses.fr (ABES) · doi:10.70675/9ba6f50czaeddz48d2zb0b6z2d35491bed8d · Cited by 1

Reverse the progression of Alzheimer’s disease through Nano-ERASER-based adult neuroregeneration

Wang, M., VanderVeen, B., Xu, Z. A., Xu, Y., Mintzer, J., Murphy, A., Zhang, Q., & Xu, P. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100575

Serum Advanced Glycation End Products Associated with NASH and Other Liver Diseases

Hyogo, H., Yamagishi, S., & Tazuma, S. (2009) · doi:10.1002/9783527628100.ch23

Estudo da degradação da proteína Tau hiperfosforilada por vias independentes do proteassoma, em modelo experimental de neurodegeneração

Farizatto, K. L. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-09122014-133659

Efectos de los productos de glicación avanzada (PGA o AGEs) sobre sus receptores en osteoblastos en cultivo

Mercer, N. (2006) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2318

The expression of inflammatory genes in human brain endothelial cells stimulated by beta-amyloid peptides is mediated by JNK-AP1 signaling pathway

Vukic, V. (2008) · uO Research (University of Ottawa) · doi:10.20381/ruor-12230

Aβ-mediated changes in CREB and ERK activity in cultured cortical neurons : involvement of NMDA receptors

de Rosa, V. (2013)

Inflammation and epilepsy: the contribution of astrocytes

Zurolo, E. (2013) · UvA-DARE (University of Amsterdam)

Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases Review Article

GRILLO, M. A., & Colombatto, S. (2008)

New Small Molecule Drug Discovery for Alzheimer's Disease

Liu, K., Zhang, M., & Nagappan, G. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-6

Characterization of Beta-amyloid Peptide Aggregation and Acceleration with Non-fibrillar Forming Peptide-based Mediators

Edwin, N. J. (2006) · doi:10.31390/gradschool_dissertations.3212

Anti-Aging Medicine LiteratureWatch

(2001) · Rejuvenation Research · doi:10.1089/10945450152466215

The Fundamental Role of Neuroinflammation at the Beginning and Progression of Alzheimer’s Disease

Sawikr, Y. (2022) · Scientific Journal for Faculty of Science-Sirte University · doi:10.37375/sjfssu.v2i2.91

Receptor for Advanced Glycation End Products in Neuronal Pathophysiology

Malik, P., Rani, R., & Mukherjee, T. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815322521125010012

Etude de l'implication des produits de glycation avancés et de leur récepteur RAGE dans la cicatrisation de l'épithélium cornéen

Gross, C. (2018) · theses.fr (ABES) · doi:10.70675/b1be30a1z4eb0z4f63z9ef9z21fe1bfd1792

BindingDB Entry 50000408: Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.

BindingDB (2019) · UC San Diego · doi:10.7270/q2kd21bp

Potential biomarkers for Alzheimer's disease and mild cognitive impairment

Mitchell, M. B. (2009)

Die Alzheimer-Krankheit: Molekulare Grundlagen und Therapieansätze

Finckh, U., Höck, C., & Nitsch, R. M. (2004) · Springer eBooks · doi:10.1007/978-3-642-18741-4_6

Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains

Nozaki, I., Watanabe, T., Kawaguchi, M., Akatsu, H., Tsuneyama, K., Yamamoto, Y., Ohe, K., Yonekura, H., Yamada, M., & Yamamoto, H. (2007) · Archivum histologicum japonicum · doi:10.1679/aohc.70.279 · Cited by 25

Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease

Choi, B.-R., Cho, W.-H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., & Han, J.-S. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.147 · Cited by 111

RAGE

Schmidt, A. M., Wautier, J., Stern, D. M., & Yan, S. D. (1998) · Elsevier eBooks · doi:10.1016/b978-012312411-1/50003-2 · Cited by 4

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain

Takeda, A., Yasuda, T., Miyata, T., Goto, Y., Wakai, M., Watanabe, M., Yasuda, Y., Horie, K., Inagaki, T., Doyu, M., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050839 · Cited by 71

Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease

Wang, M. Y., Ross-Cisneros, F. N., Aggarwal, D., Liang, C.-Y., & Sadun, A. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0513-4 · Cited by 38